期刊文献+

妊娠合并心脏病患者MMP-1、GATA6、PTX3水平与不良妊娠结局的关系研究 被引量:3

Relationship between the level of MMP-1,GATA6 and PTX3 and adverse pregnancy outcomes in pregnant women complicated by heart disease
下载PDF
导出
摘要 目的探讨妊娠合并心脏病患者基质金属蛋白酶-1(MMP-1)、GATA结合蛋白6(GATA6)、正五聚蛋白3(PTX3)与不良妊娠结局的关系。方法选取2019年1月至2021年1月温州市中西医结合医院收治的妊娠合并心脏病患者42例,根据是否发生不良妊娠结局分为观察组(20例)和对照组(22例),比较两组的妊娠风险及MMP-1、GATA6 mRNA和PTX3水平,分析MMP-1、GATA6 mRNA和PTX3与妊娠风险分级关系及预测不良妊娠结局的价值。结果观察组妊娠风险分级与对照组比较,差异有统计学意义(P<0.05)。观察组MMP-1、PTX3高于对照组,GATA6 mRNA低于对照组,差异均有统计学意义(均P<0.05);MMP-1和PTX3与妊娠风险分级呈正相关(r=0.598、0.829,均P<0.05),GATA6 mRNA与妊娠风险分级呈负相关(r=-0.690,P<0.05)。多因素logistic回归分析显示MMP-1、GATA6 mRNA和PTX3是不良妊娠结局的相关影响因素(均P<0.01);联合MMP-1、GATA6 mRNA和PTX3预测不良妊娠结局的AUC大于MMP-1、GATA6 mRNA或PTX3单一预测。结论MMP-1、GATA6和PTX3与妊娠合并心脏病患者不良妊娠结局有关。 Objective To investigate the relationship between matrix metalloproteinase-1(MMP-1),GATA binding protein 6(GATA6)and pentraxin 3(PTX3)and adverse pregnancy outcomes in pregnant women complicated by heart disease.Methods Forty-two pregnant women with heart disease admitted to Wenzhou Integrated Traditional Chinese and Western Medicine Hospital from January 2019 to January 2021 were enrolled and divided into obersavation group(20 cases)and control group(22 cases)according to pregnancy outcomes.Pregnancy risk,MMP-1,GATA6 mRNA and PTX3 were compared between the two groups.The relationship between MMP-1,GATA6 mRNA and PTX3 and pregnancy risk classification were analyzed.The value of MMP-1,GATA6 mRNA and PTX3 in predicting adverse pregnancy outcomes was determined.Results The pregnancy risk classification was significantly higher in obersavation group than in control group(P<0.05).MMP-1 and PTX3 were significantly higher and GATA6 mRNA was significantly lower in obersavation group than in control group(all P<0.05).MMP-1 and PTX3 were positively correlated with pregnancy risk classification(r=0.598,0.829,all P<0.05),and GATA6 mRNA was negatively correlated with pregnancy risk classification(r=-0.690,all P<0.05).Multivariate logistic regression analysis showed MMP-1,GATA6 mRNA and PTX3 were influence factors of adverse pregnancy outcome(all P<0.01).The area under the curve for predicting adverse pregnancy outcome was significantly higher using a combination of MMP-1,GATA6 mRNA and PTX3 than using MMP-1,GATA6 mRNA or PTX3 alone.Conclusion MMP-1,GATA6 and PTX3 are related to adverse pregnancy outcomes in pregnant women with heart disease.
作者 朱淑嫔 姚锐 金纬纬 ZHU Shupin;YAO Rui;JIN Weiwei(Department of Gynaecology,Wenzhou Integrated Traditional Chinese and Western Medicine Hospital,Wenzhou 325000,China)
出处 《心电与循环》 2022年第1期53-57,共5页 Journal of Electrocardiology and Circulation
基金 浙江省医药卫生科技计划项目(2020KY923)。
关键词 基质金属蛋白酶-1 GATA结合蛋白6 正五聚蛋白3 妊娠 心脏病 预后 MMP-1 GATA6 PTX3 Pregnancy Heart disease Outcome
  • 相关文献

参考文献4

二级参考文献39

  • 1Evangelista A, Avegliano G, Aguilar R, et al. Impact of contrast-enhanced echocardiography on the diagnostic algorithm of acute aortic dissection[J]. Eur Heart J, 2010,31(4): 472-479.
  • 2ACOG Committee on Obstetric Praetiee. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy[J]. Obstet Gynecol, 2004, 1 04(3):647-651.
  • 3Kampman MA, Balei A, van Veldhuisen DJ, et al. N-terminal pro-B-type natriuretie peptide predicts cardiovascular complications in pregnant women with congenital heart disease [J]. Eur Heart J, 2014,35(11):708-715.
  • 4European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) [J]. Eur Heart J. 2011,32(24):3147-3197.
  • 5Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease[J]. Circulation, 2001,104(5):515-521.
  • 6Drenthen W, Boersma E, Balei A, et al. Predictors of pregnancy complications in women with congenital heart disease[J]. Eur Heart J, 2010,31(17):2124-2132.
  • 7Hurst JW. The value of using the entire New York Heart Association' s classificationof heart and vascular disease[J]. Clin C ardiol, 2006, 29(9):415-417.
  • 8Mukoyama M, Nakao K, Hosodo K, et al. Brain natriureticpeptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide[J]. J Clin Invest, 1991, 87(4):1402-1412.
  • 9Kim SW, Park SW, Lira SH, et al. Amount of left ventrieular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction [J]. Clin Cardiol, 2006,29(4):155-160.
  • 10Gali N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) [J]. Eur Heart J, 2009,30(20):2493-2537.

共引文献235

同被引文献18

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部